1.1 (1) The Lieutenant Governor in Council shall appoint an executive officer for the Ontario public drug programs.  2006, c. 14, s. 7. Functions and powers (2) Subject to this Act and the regulations, it is the function of the executive officer, and he or she has the power, to perform any functions or duties that he or she may have under this Act and the regulations, under the Drug Interchangeability and Dispensing Fee Act and its regulations and under any other Act or regulation, and without in any way restricting the generality of the foregoing, (a)  to administer the Ontario public drug programs; (b)  to keep, maintain and publish the Formulary; (c)  to make this Act apply in respect of the supplying of drugs that are not listed drug products as provided for in section 16; (d)  to designate products as listed drug products, listed substances and designated pharmaceutical products for the purposes of this Act, and to remove or modify those designations; (e)  to designate products as interchangeable with other products under the Drug Interchangeability and Dispensing Fee Act, and to remove or modify those designations; (f)  to negotiate agreements with manufacturers of drug products, agree with manufacturers as to the drug benefit price of listed drug products, negotiate drug benefit prices for listed substances with suppliers, and set drug benefit prices for designated pharmaceutical products; (g)  to require any information that may or must be provided to the executive officer under this Act or the regulations or any other Act or regulation to be in a format that is satisfactory to the executive officer; (h)  to make payments under the Ontario public drug programs; (i)  to establish clinical criteria under section 23; and (j)  to pay operators of pharmacies for professional services, and to determine the amount of such payments subject to the prescribed conditions, if any.  2006, c. 14, s. 7. (3) Repealed: 2019, c. 14, Sched. 11, s. 1. Transitional (4) An agreement concerning the Ontario drug programs to which the Minister was a party and that was in effect immediately before October 1, 2006 continues in force, with the executive officer substituted for the Minister, until it is terminated under its terms.  2006, c. 14, s. 7. Review process (5) The Minister shall establish a process to review, (a)  recommendations made to the executive officer in respect of his or her functions under clause (2) (d) concerning the designation of products as listed drug products; and (b)  decisions made by the executive officer not to designate a product as a listed drug product under clause (2) (d) where a recommendation to designate has been made by a body that advises the executive officer.  2006, c. 14, s. 7. Publication (6) The Minister shall publish the details of the process established under subsection (5) on the website of the Ministry and in any other format the Minister considers advisable.  2006, c. 14, s. 7. Non-application of SPPA (7) The Statutory Powers Procedure Act does not apply to a review carried out under the process established by the Minister under subsection (5).  2006, c. 14, s. 7. Non-application of SPPA (8) The Statutory Powers Procedure Act does not apply to any decision or action of the executive officer under this Act.  2006, c. 14, s. 7. Regulations (9) The Lieutenant Governor in Council may make regulations, (a)  clarifying, modifying or restricting the functions and powers of the executive officer; (b)  providing for additional functions and powers of the executive officer.  2006, c. 14, s. 7. Section Amendments with date in force (d/m/y) 2006, c. 14, s. 7 - 01/10/2006 2019, c. 14, Sched. 11, s. 1 - 01/04/2016